Sign up
Title:
AQUEOUS-BASED PERSONAL CARE PRODUCT FORMULA THAT COMBINES FRICTION-CONTROLLED FRAGRANCE ENCAPSULATION TECHNOLOGY WITH A FILM FORMING COMPOUND TO IMPROVE ADHERENCE OF CAPSULES ON KERATINOUS SURFACES
Kind Code:
A1
Abstract:
The present disclosure relates to an aqueous microcapsule composition comprising & plurality of microcapsule particles, a film-forming mixture, and an aqueous solvent. Each microcapsule particle comprises a sol-gel material and a volatile oil-soluble active ingredient encapsulated by the sol-gel material. The film-forming mixture of the present disclosure extends the efficacy of the volatile oil-soluble active ingredient encapsulated in the microcapsule particles by improving the adherence of the microcapsule, particles to the substance to which the aqueous microcapsule composition is applied (e.g., a keratinous substance or a fabric). The aqueous microcapsule composition of the instant disclosure- - which is free of formaldehyde andstable in aqueous solvents - is. well-suited for use in aqueous personal care products.


Inventors:
ALDEN-DANFORTH, Ethan (134 9th Avenue, Apt. 2RNew York, NY, 10011, US)
FEUER, William (48 Beverly Drive, Hillsborough, NJ, 08844, US)
WHITE, Michael (3 Furlong Drive, Millstone Township, NJ, 08535, US)
WILLIAMS, Nancy (13 Angelina Court, Monroe Twp, NJ, 08831, US)
Application Number:
US2012/071961
Publication Date:
07/04/2013
Filing Date:
12/28/2012
Assignee:
L'OREAL (14 Rue Royale, Paris, Paris, FR)
ALDEN-DANFORTH, Ethan (134 9th Avenue, Apt. 2RNew York, NY, 10011, US)
FEUER, William (48 Beverly Drive, Hillsborough, NJ, 08844, US)
WHITE, Michael (3 Furlong Drive, Millstone Township, NJ, 08535, US)
WILLIAMS, Nancy (13 Angelina Court, Monroe Twp, NJ, 08831, US)
International Classes:
A61K8/11; A61K9/50; B01J13/18
View Patent Images:
Foreign References:
200803177952008-12-25
201001046132010-04-29
201202375782012-09-20
201001434222010-06-10
Attorney, Agent or Firm:
BALLS, R., James (Connolly Bove Lodge & Hutz LLP, 1875 Eye Street NW,Suite 110, Washington DC, 20006, US)
Claims:
What is claimed is:

1. An aqueous microcapsule composition comprising:

a. a plurality of microcapsule particles, wherein each microcapsule particle comprises: i. a sol-gel material: and

si. a volatile oil-soluble active ingredient encapsulated by the sol-gel material; b. a film-forming mixture comprising a€5 ,22 fatty alcohol and an C -20

aikyf poly glycoside and

c. an aqueous solvent.

2. The aqueous microcapsule composition according to claim 1. wherein the composition comprises:

a. about 0.01 wt. % to about 6 wt. % of the microcapsule particles;

b. about 0.1 wt. % to about 15 wt % of the fiira-forming mixture; and

e. about 25 wt. % to about 90 wt. % water,

wherein the wt %, in each ease, is relative to the total, weight. of me aqueous microcapsule- composition.

3. The aqueous microcapsule composition according to claim I , wherein -the fiim-ihrmmg mixture is a mixture selected from the group consisting of a cetylstearyl aleohoi/eocoglueoside mixture, an araehidyl alcohol and behen l alcohoi/arachidylglucoside mixture, a myrisiyl aieohoi/myristylgiueoside mixture, a cetylstearyl aicohol/ce'tylstearylglucoside mixture, a CM- C22 alcohol Cis-Cso alkylgiuc side mixture, a cocoalcohol/cpcoglucoside mixture, and an isostearyl alcohol/isostearylglucoside mixture.

4. The aqueous microcapsule, composition according to claim I , wherein the sol-gel material is a metal or semi-metal alkoxide monomer, a metal ester monomer, a semi-raetal ester monomer or an alkoxysliartes .monomer corresponding to the formula:

wherein M is Si, Ti, or Zr; X is hydrogen or -OR?,; X' is hydrogen, or --0¾; and R>? R2, 3 and R4, independent of each other, represent a li near or branched alky I group,

5. The aqueous microcapsule composition, according to claim 1, wherein the so!-gei materia! is tetraraethyl ofihos.iheate, tetraeth yl orthesi!icate, or a mixture- thereof.

6. The aqueous microcapsule composition according to claim i, wherein the aqueous sol ent is water,

7. The aqueous microcapsule composition according to claim 3. wherein the film-forming mixture is a C1 -C2? aic0hoi/Co»C¾ aiky!glucoside mixture and the aqueous solvent is water.

8. The aqueous microcapsule composition according to claim 1 , wherein the composition is free of formaldehyde .

¾, The aqueous microcapsule .composition according to claim 3 , wherein the volatile oil- soluble active ingredient comprises a fragrance.

10, A method of scenting a human keratinous substance 'comprising applying the aqueous microcapsule composition according to claim 9 to the human keratinous substance.

1 1 , The aqueous microcapsule composition according to claim 9, wherein the volatile oil- soluble active ingredient further comprises at least one deodorant active, principle and/or at least one antiperspirant active principle.

1.2, A method of treating a human body odour comprising applying an effective amount of the aqueous microcapsule composition according, to claim 1 1 to a surface of human skin. ! 3. The method according to claim 12, wherein the effective amount of the aqueous microcapsule composition is applied to a surface of human armpit skin.

14. The method according to claim 12, wherein the effective amount of the aqueous microcapsule composition is applied to a surface of human foot skin.

15. An aqueous-based personal care product comprising the aqueous microcapsule composition according to claim I .

16. The aqueous-based personal care product according to claim 1 S, wherein the personal care product is selected from the group consisting of shampoos, hair rinses, body washes, soaps, anti-perspirants and deodorants*

17. The aqueous-based personal care product according to claim .16, wherein the personal care product is a roll-on deodorant or antiperspirant product

18. The aqueous-based personal care product according to claim 16, wherein the personal care product is ah emulsion-based deodorant and/or antiperspirant stick.

1 . The aqueous-based personal -care product according to claim 16< wherein' the personal .care product is a deodorant and Or antiperspirani aerosol product.

Description:
UNITED STATES PATENT APPLICATION

OF

ETHAN ALDEN-D ANF TH, WILLIAM FEUER, MICHAEL WHITE. AND NANCY WILLIAMS

FOR

AQUEOUS-BASED PERSONAL CARE PRODUCT FORMULA THAT COMBINES FRICTION-CONTROLLED FRAGRANCE ENCAPSULATION TECHNOLOGY

WITH A FILM FORMING COMPOUND

TECHNICAL FIELD

The present disclosure relates to an aqueous microcapsule composition comprising a plurality of microcapsule particles and a film-forming mixture. The aqueous microcapsule composition - which is free of formaldehyde - is well suited for aqueous-based personal care products.

BACKGROUND OF THE DISCLOSURE

Fragrance chemicals are used in numerous products to enhance the consumer's enjoyment of a product. For instance, fragrance chemicals are added to consumer products such as laundry detergents, fabric softeners, soaps, detergents, and personal care products such as, but not limited to, shampoos, body washes, deodorants, antiperspirants, and hair-styling products. in order to enhance the effectiveness of the fragrance materials for the user, various technologies have been developed to help prevent imgrance degradation: and loss. One widel used technology involves encapsulation f a fragrance material in a protective coating. The protective- coating is typically a polymeric material that protects the fragrance material from evaporation, reaction,, oxidation or dissipation prior to use. Examples of such polymeric encapsulated fragrance materials are disclosed in U.S. Fat. Nos. 4,081,384, 5,112,688, 5,145,842, and 6,248,703.

While encapsulation technologies have improved the tenacity of fragrance materials, most if not all encapsulated fragrance materials either contain traces of formaldehyde and/or are starch-based. Encapsulated fragrance materials containing formaldehyde are wholly

unacceptable by personal care industry standards and thus cannot be utilized in personal care products. Furthermore, starch-based encapsulations cannoi be formulated into aqueous personal care products. Therefore, there Is a need for a formaldehyde-free encapsulated fragrance materia! that ears be formulated into aqueous personal care products.

SUMMARY OF THE DISCLOSURE

The present disclosure relates to an aqueous microcapsule- compositi n comprising a plurality of microcapsule particles, a film-forming mixture, and. an aqueous solvent. Each microcapsule particle comprises a sol-gel maierial and a volatile oil-soluble active ingredient encapsulated by the sol-gel material. The film-forming mixture of the present discbsure extends the efficacy of the volatile oil-soluble active ingredient encapsulated in the microcapsule particles by improving the adherence of the microcapsul particles to the substance to whic the aqueous microcapsule composition is applied (t¾g,} a keratmous substance or a fabric). The aqueous microcapsule composition of the instant disclosure - which is free of formaldehyde and stable in aqueous- solvents - is well-suited for use in aqueous-based personal care products.

.Accordingly, a second: aspect of the disclosure -relates to aqueous-based personal care products comprising the aqueous microcapsule Composition described herein, in a particular aspect of the disclosure, the aqueous-based personal care product is an anti-perspirant or a deodorant comprising the aqueous microcapsule composition described herein.

Another aspect of the disclosure relates to a method of depositin the plurality of microcapsule particles on te a substrate comprising applying the aqueous microcapsule composition described herein to the substrate.

Yet another aspect of the -disclosure relates to a method of scenting a substrate comprising applying an aqueous microcapsule composition of the instant, disclosure to the substrate, wherein the volatile oil-soluble active ingredient of the aqueous microcapsule composition comprises a fragrance. Another aspect of the disclosure relates to a method of treating human body odour comprising applying an aqueous microcapsule composition of instant disclosure to a surface of human skin. In this aspect of the disclosure, the volatile oil-soluble active ingredient used in the aqueous microcapsule composition described herein comprises at least one deodorant active principle and/or at least one anfi-perspirant salt or complex.

DESCRIPTION OF BEST AND VARIOUS EMBODIMENTS OF DISCLOSURE

The term "comprising" (and its grammatical, variations) as used herein is used In the inclusive sense of "having" or 'including'' and not in the exclusive sense of '"consisting only of," The terms "a" and "the" as used herein are understood to encompass fee plural as well as the singular.

The term '"volatile* as used, herein refers to compounds w ich are liquid at ambient temperature and which have a nonzero vapour pressure at ambient temperature and atmospheric pressure, ranging in particular from 0.13 Fa to 40,000 Pa (10'"' to 300 mmHg}, in particular ranging from- 1.3 Pa to 13,000 Pa (0.1 to 100 mmHg) and more particularly ranging from 13 Pa to 1300 Pa (0.01 to 10 mmHg).

The term, "oil-soluble," as used herein, refers to an ingredient having solubility in distilled water at ambient temperature of less than about 1 gram/.100 mL, More typically, the oil- soluble 'ingredients mentioned herein have a solubility in distilled water at ambient temperature of less than about 0.5 grams/100 mL, and most typically have a solubility in distilled water at ambient temperature of less than about 0.1 gram/100 mL.

The term "human keraiinous substance/' as used herein, is understood to mean the skin, hair, scalp, eyelashes, eyebrows, nails or Hps. The term "effective amount," as used herein, is understood to mean the minimum quantity necessary to produce the intended or expected result

As used herein, the expression "at least one," means one or more and thus includes individual components as well as mixtures combinations.

Other than is the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients- and/or reaction conditions are to he understood as being raod ed in all instances by the term ''"shout." meaning within 10% to 15% of the indicated number.

A first aspect of the disclosure relates to an aqueous microcapsule composition comprising:

a. a pluralit of microcapsule particles, wherein each microcapsule particle

comprises:

L a sol-gel material: and

ii. a volatile oil-soluble active ingredient encapsulated by the sol-gel

material.;

b. a film-forming, mix re comprising a C 1 -22 fatt alcohol and a Cn-zo

alkyipolyglycoside; and

c. an aqueous solvent.

The aqueous microcapsule compositions of the instant disclosure typically comprise about 0.01 wt. % to about 6 wt % microcapsule, particles, about 0.1 wt. % to about 15 wt. % of a film-forming mixture,, and about 25 -wt. % to about 90 wt % water, wherein the wt%5 in each case., is relative to the total weight of the aqueous microcapsule composition. More typically, the aqueous microcapsule compositions of the instant dictosare comprise about 0.1 wt. % to about 3 wt % microcapsule particles, about 0.5 wt. % to about 10 wt. % of a film-forming mixture, and about 35 wt. % to about 80 wt. % water, wherein the wt.%, in each case, is relative to the total weight of the aqueous microcapsule composition. Most typically, the compositions discussed herein comprise about 0.2 wt % to about 2 wt, % microcapsule particles, about I wt % to about 5 wt. % of a film-forming mixture, and about 45 wt % to about 70 wt. % water, wherein, the wt.%, in each case, is relative to the total weight of the aqueous microcapsule composition.

The volatile oil-soluble active ingredient of the instantly disclosed aqueous microcapsule compositions is encapsulated by a sol-gel material. Sol-gel precursors (ie,, starting compounds capable of terming sol-gel material suitable for the purposes of the instant disclosure) are well known in the. art, Sol-gel precursors usable in accordance with the disclosure include, for example, compounds, which are capable of forming gels, such as silicon, boron, aluminum, titanium, zinc, zircon um and vanadium. According to one aspect of the disclosure, sol-gel precursors are -silicon, boron and aluminum compounds, and more particularly organo-stlicon, organoboron and organoalumiaum compounds. The precursors can also include metal slkoxides and b-diketonates.

Sol-gel precursors suitable for the purposes: of the disclosure are selected in particular from the group of di-, tri- and or ietrafunctional silicic acid, boric acid and alumoesters, more particularly alkoxysilanes (alky! or hosiHcates), and precursors thereof.

One example of a sol-gel precursor suitable for the purposes of the instant disclosure are alkoxysilanes corresponding to the following general formula;

wherein X is hydrogen or -OR3;X* is hydrogen or -OR4;. and R3 , R2, R3 and ¾, independent of each other, represent a linear or branched alkyl group. More typically, ¾, R¾ R% and R4, independent of each other, is a Cj.j2 alkyl M is Si, Ti or Zr.

Another example of a sol-gel precursor that is typically used in the aqueous microcapsule compositions of the instant disclosure are alkoxy si fanes corresponding to the following general formula:

(RsO)(R20)Si(X)(X;)

wherein X is hydrogen or -OR?,; X' is hydrogen or -OR*; and Rj, R2, R.j and R4, independent of each other, represent a linear or- branched alkyl group. More typically, Ri, R2, R3 and R,¾, .independent of each other, is a C- % alkyl M is Si, Ti or Zr.

According to one aspect, of the disclosure, silicic acid esters teirarnethyl orthosilicate (TMOS) -and tetraethyi orthosiiicate (TEOS) are used as sol-gel precursors. Typically,

Dynasylan® (c-ommerciai!y available from egussa Corporation, Parsippany N.J.. USA) is used. Other sol-gel precursors suitable for use in the instantly disclosed aqueous microcapsule compositions are described, for instance,, in German Patent Application DE 10021165. These sol-gel precursors are various hydroiysabJe organosUa es such as, alkylsilanes, aikdxysilanes. a.lkyi alko ysisanes and. organcdfeoxysilanes. Besides the alkyl and alkoxy groups, other organic- groups for example, -a!lyl groups, am noaikyl groups, hydroxvaikyi groups, etc.) may be attached as substituents to the silicon.

The particle size of each of the microcapsule particles according to the instant disclosure may be in the range of about 0.01 -1000 microns in diameter. More typically, the microcapsule particles are about 0.1-100 microns in diameter, and most typically the microcapsule particles are about 1-10 microns in diameter. The aqueous microcapsule compositions of the instant disclosure also comprise a volatile oil-soluble active ingredient. A common feature of many encapsulation processes is that they require the material to be encapsulated to be di spersed in aqueous solutions of polymers, pre- eondensates, surfactants,, and the like prior to formation of the microcapsule walls. Therefore, materials having low solubility in water, such as highly hydrophobic materials are typically used as the volatile oil-soluble active ingredients, as they will tend to remain in the dispersed phase and partition only slightly into the aqueous sol vent of the instantly disclosued aqueous microcapsule compositions.

Examples of volatile oil-soluble active ingredients that are-suitable for use i the aqueous-based compositions described herein- include, but are not limited to, aromatics (e.g. , fragrances), pesticides, herbicides, greasing agents, lubricants, insecticides, antimicrobial agents, pharmaceutical/therapeutic agents (e.g. , an anti-infective, an antibiotic, an antibacterial agent, an anti-fuhga. agent, ah antiviral agent, an antiparasitic agent, an anti-inflammatory agent, an anesthetic, an analgesic, an anti-allergic agent, a corticosteroid, a retinoid, an antiproliferative agent, an. anticancer agent, a photodynaraic therapy agent, a lubricating agent, hormones, ache active ingredients,, astringent .acti e ingredients, or a mixture thereof), nutritional ingredients (e.g...vitamins, minerals) cosmetic agents (e.g., a retinoid, an anti-wrinkle agent, a radical scavenger, a self-tanning. gent, a skin whitening agent, a skin protective agent, an anti-celiu!ite agent, a massaging oil or an anti-wart agent dandruff agents), deodorant active principles, anti- perspirant salt -or complexes, latent heat .storing agents («.#., waxes), catalysts (e.g.. organic carbonates), self-healing agents (e.g.* norbomes, dicyclopentadiene), coating systems (e.g., lacquers), hydrophobic waxes, or hydrophobic solvents. Such ingredients include the ingredients described in WO 201 1/1 10368, U.S. 2008/0050317 d US, 20090053301, all of which are incorporated herein by reference.

Typically, the volatile oil-soluble. active ingredient is a fragrance, essential oil, plant extract, or any mixture thereof that is compatible with, and capable of being encapsulated by a monomer or polymer.

Many iypes of fragrances can be utilized in the instantly disclosed aqueous microcapsule compositions so long as the fragrances are compatible with the monomer or polymer in which they are encapsulated, and the .fragrances' are capable of being encapsulated by the monomer or polymer. For instance, suitablefragrances include but are not limited to almond, fruits such as apple, cherry, grape, pear, pineapple, orange strawberry, raspberry; musk,, flower scents such as lavender-like, rose-like, iris-like, and carnation-like. In addition, other pleasant scents such as herbal scents {e.g., rosemary, thyme, and sage), and woodland scents derived from pine, spruce .and other forest smells. The instantly disclosed aqueous microcapsule compositions may also, comprise fragrances derived, from various' oils such as essential oils, or .from plant materials such as peppermin spearmint and the like. Other familiar and popular fragrances can also be.

employed in the instantly disclosed compositions. Such fragrances include bab powder, popcorn, pizza, cotton candy and the like.

A list of suitable fragrances is provided in U.S. Pat. Nos. 4,534,891 , 5,112,688, and 5,145,842 as well as U.S. 2010/0247660 and U.S. 20100143422- all of which are incorporated herein by reference. Another source of suitable fragrances is found in Perfumes Cosmetics and Soaps. Second Edition, edited by W.A. Poucher, 1 59 (also incorporated herein by reference). Among the fragrances provided n this treatise are acacia, cassie, chypre, eylaraen. fem, gardenia, hawthorn, heliotrope, honeysuckle,, hyacinth, jasmine, lilac, lily, magnolia, mimosa, narcissus, freshly-cut hay, orange blossom, orchids, reseda, sweet pea, trefJe, tuberose, vanilla, violet, wallflower, and the like.

The level of fragrance in the microcapsules of the nstant disclosure varies from about 5 to about 95 weight percent. Typically, the level offragrance in the microcapsule is from about 30 to about 95 weight percent, and most typically from about 50 to shout 90 weight percent. The weight percent, in each case, is relative to the total dry weight of the microcapsule. Other agents can be used m conjunction with the fragrance and are understood to be included in the present disclosure.

The fragrance used in the microcapsule particles of the instant disclosure may be combined with a variety of solvents- which serve to increase the compatibility of the various materials, increase the 'overall -hydrophobicity of the blen'd, influence: the vapor pressure of the materials, or serve to structure the blend. Solvents performing these functions are well known in the art and include mineral oils, triglyceride oils, silicone oils, fats, waxes, fatty alcohols, diisodecyl adipate, and diethyl phthalate among others.

Fragrance materials with Clog P values greater than ! , and more typically greater than 3, and most typically greater than 5 will thus result in microcapsules that will have less possibility of reacting with, materials that form the capsule shell (etg.; the sol-gel materials). Surfactants contemplated for use in the- present disclosure may be anionic, nonionic or cationk surfactants.

Typically, surfactants utilized in the aqueous microcapsule compositions of the instant disclosure exhibit an MLB ranging from 8 to 12. Examples of surfactants exhibiting an HLB ranging from S to 12 include, but are not limited to:

ethers of polyethylene glycol and/or of poly-propylene glycol and of fatty alcohols, in particular of alcohols comprising from 12 to 30 carbon atoms, typically from. 14 to 22 carbon atoms, such as tridecyl alcohol, cety! alcohol, stearyi alcohol or iauryl alcohol, the ether comprising in total from 2 to 30 oxyethyfene (OE) and/or oxypropylene (OP) groups, typically from 1 to 20 oxyethylene groups and/or from 1 to 10 oxypropylene groups, such as, for example, the compounds having the INC! names steareth-8, steareih-10, sieareih-l 6, steareth-20, ceteth-1.0, laureth-4, laureth-3 (such as Remcopal 121 from Ceca S.A.), tridece h-6 (such as Renex 36 from ICI Surfectants), ceteareth-5 (such as Voipo CS 5 from Croda), oleih-10 (such as Volpo N 10 from Croda), beneih~i0 (such as Nikko! BB-10 .from Nikkol), the ether of.oleyi alcohol and of polyethylene glycol comprising 4,5 OE groups (such as, tor example, R mcopaf 220 .from Ceca S.A.j, the poiyoxy-propylenated (40Pypolyoxyethylenated ( 1 OE) ether of cetyi alcohol (such as Nikkol PBC-3 I from Nikkol) or the pofyoxypropyienated (4QPypoIyoxy-ethy1enated (10 OE) ether ofcetyl alcohol (such as Nikkol PB€-33 from Nikkol),

esters of polyethylene glycol and/or of poly-propyle e glycol and of fatty acids, in particular of faiiy acids comprising from 3 to 30 ' carbon atoms, typically from 14 to 26 carbon atoms, such as oleic acid or stearic acid, comprising from 1 to 50 oxyethylene (OE) groups", typically from 4 to 12 oxyethylene groups, such as, for example, polyethylene g!ycoI-8 motiostearate (or pojyoxye hylenated 8-OB monostearate), polyethylene glycol- 10 monostearate (or

polyoxyethylenated 10 OE monostearate), or polyethylene glycol- 12 distearate (or

polyoxyethylenated 12 OE distearate),

ethers resulting from the reaction of a) polyethylene glycol and of b) esters of fatty acids (in particular of Cs z-Cjo and usually C -C^; acids) and of glucose which are oxyethyienaied (which can comprise from 1 io 50 oxyethylene groups, usually from 4 to 10 oxyethylene groups, and from 1 to 10 glycosyl groups), -such as ethers of polyethylene glycol and of esters of stearic acid and of glucose, such as polyoxyethylenated (20 OE) methyl, glucose distearate, ethers of alcohols comprising from 12 to 30 carbon atoms, typically from 14 to 22 carbon atoms, and of glycerol or of poIyglyceroL the ethers comprising from 3 to 10 glycerol groups, such as, for example, polyglyeeryl~3 cetyi ether, such as Chimexane L from Chimex,

esters of tatty acids comprising from 12 to 30 carbon atoms, better still from 14 to 20 carbon atoms, such as stearic acid, and of glycerol or of poiyglycerol, the esters comprising from 3 to 10 glycerol groups, such as. for example, hexa-glyceryl monostearate, it being possible for these glycerol or polyglyeerol -esters to comprise from 1 to 10 fatty chains;

esters of sucrose or of glucose and of fatty acids comprising, from. 12 to 30 carbon atoms,, in particular from 14 to 20 carbon atoms; mention may be made, for example, of the mixture of esters (mono- and polyesters) of stearic acid and. of sucrose .sold, by Croda under the reference

Crodes a Fl 10,

ethers offa'tty alcohols comprising from 12 to 30 carbon atoms, in particular from 12 to 20 carbon atoms, and of sucrose or of glucose, in particular ethers of fatty alcohols comprising from 1.2 to 20 carbon atoms and of glucose, comprisin in particular' from 12 to 3 glycoside units, such .as the. compounds carrying the i C'I names CI2-18 alkylg-lucos'ide, CI 2-20 atky!gkeoside (tor example Montanov L from Seppic), cetearyl glucoside (such as, for example, that which is sold as a mixture with cetearyl alcohol under the reference Montanov 68 from Sepp c), niyristy! glucoside (such as, for example, that which is sold as a mixture with niyristy! alcohol under the reference Montanov 14 from Seppic) or cetearyl glucoside (such as Tegocare CG 90 from Evonik Goldschrnidt),

esters of sorbitol and/or of sorbitan and of fatty acids comprising from 12 to 30 carbon atoms, typically from 12 to 20 carbon atoms, such as lauric acid; mention may be made, for example, of sorbitan laurate, such as Span 20 from Um e.ma, ethers of sorbitol and/or of sorbitan, such as ethers of beeswax and of eihoxyiated sorbitan comprising from 5 to 25 OE groups, such as, for example, Sorbeth-8 beeswax or Sorbeth-20 beeswax from GBW-125 Nikko Chemical,

esters of fatty acids (in particular of C32-C30 and typically Q2-C20 acids) and of oxyethy!enated ethers of sorbitol and/or of sorbitan (which can comprise from 2 to 30 oxyethylene groups), such as esters of stearic acid and of sorbitol and or of sorbitan comprising from 2 to 20 OE groups, such as polysorbate-60, polysctrbaie-61, sorbeth-3 isostearate, poiyoxyethylenated 4 OE sorbitan monostearate or polyoxyethy!enated 20 OE sorbitan tristearate,

ethers of polyethylene glycol and of cholesterol comprising from 5 to 40 oxyethylene groups, such as, for example, cho!eth-10 (such as Emalex CS-10.from Nihon Emulsion Company), choleth-15 (such, as Emalex CS-15 from Nihon Emulsion Company) or choieth-20 (such as. Emalex CS-20 from Nihon Emulsion Company),

and their mixtures.

The aqueous microcapsule compositions of the instant disclosure also comprise a film- forming mixture. The film-forming mixture. comprises a C 1 .2.1 laity alcohol and a C^so.

a!kyipolyg!ycoside. For the purposes of the present disclosure, an "alkyspolyglycoside" means an alkylnionoside (degree of polymerization; 1) or alkylpoiyoside (degree of polymerization: more than 1).

The alkylpolyglyeosides may be used alone or in the form of mixtures of two or more a Ikylpol glycosides. They conform, in general, to the following structure:

R(0)(G)x

in which the radical R is a linear or branched Ci2-C22 alkyl radical, G is a saccharide residue, and x is from I to 5, typically from 1.05 to 2.5, and more typically from 1.1 to 2. The saccharide residue may be selected from glucose, dextrose,, sucrose, fructose, galactose, maltose, ma!totrtose, lactose, cellobiose, mannose, ribose, dexiran, taiose, allose, xylose, ievogluean, cellulose or starch. More typically the saccharide residue denotes glucose.

It should additionally he noted thai each unit of the polysaccharide portion of the alkylpolyglycoside may be in L or D form, and that the configuration of the saccharide residue may be of futanoside or pyranoside type.

it is of course possible to use mixtures of alkyipolysaediarides, which may differ from one another in the nature- of the a!kyl moiety borne and/or in the nature of the bearin polysaccharide chain .

The alkylpolyglycoside is used in a mixture with at least one fatty alcohol, especially a fatty alcohol having from 10 to 30 carbon -atoms, and more particularly from 12 to 22 carbon atoms. Examples of fatty alcohols which can be used in combination with the

alkyipolyglyeoside(s) of the film-forming mixtures -according to the instant disclosure include linear or branched fatty lcohols. of synthetic origin or else of natural origin, such as, for example, the alcohols originating from plant substances (coconut, palm kernel, palm, ere.) or animal substances (tallow, etc.). Of course, other long-chain alcohols may a lso be used, for example -ether alcohols or else what are known as Guerbet alcohols. It is also possible to use certain longer or shorter fractions of aicohb Is' of natural origin, for example coco (C & to CM) or tallow (Cu to Cn) or diol compounds or cholesterol.

Typically, a fatty alcohol comprising from 10 to 26 carbon atoms, and more typically from 10 to 24 carbon atoms and most typically from 12 to 22 carbon atoms is used in the film- forming mixtures of the instant disclosure. Particular examples of fatty alcohols which can he used in the context of the present- disclosure include !auryi alcohol, myristyl alcohol, cei l alcohol siearyt alcohol, isostearyl alcohol, pa!mityS alcohol, o!eyl alcohol, ceteary! alcohol {a mixture of ceiyl alcohol and stear l alcohol), behenyl alcohol, eruc l alcohol, arachkiyl alcohol and mixtures thereof. Most typically, eeiearyl alcohol is employed. Fatty alcohols of these kinds are especially sold under the name afol by the company Sasol.

Moreover, it is- articularly advantageous, according to the present disclosure, to employ simultaneously a fatty alcohol and an alkytpolyglycoslde in. which, the alkyi portion is identical to that of the fatty alcohol employed. Such fatty alcohol/alky lpolygIycosi.de -film-forming mixtures are known per se. They are described especially in patent applications WQ 92/06778, WQ

95/13863 and WO 98/47610 (all of which are incorporated herein by reference), and are prepared by the preparation processes Indicated in these documents.

The fatty alcohol/alkylpo'lyglycoside mixtures typically include the products, sold by S'BPPIC under the outattov names, 'such as the fol lowing mixtures:

cetylstearyl alco'hoI cocoglucoside-Montenov 82®.,

arachidyl alcohol and behenyl'alcohol arachidylglucoside-Montanov 802·®,

myristyl alcohoi/myrist 'lglucoside~Montanov 14 ,

cetylstearyl alcohol/cetylsteatylglucoside-Monianov

CM-CB akohof/Ci Cjo alkylgiucoside-- Monianov L®,

cocoakoho!/cocoglucoside— Montanov S®.. and

isostearyl alcohol/isostearylglucoside--Montanov WO 18®.

The total amount of film-forming mixture in the aqueous microcapsule compositions described herein will depend on the volatile oil-soluble active ingredient used. Typically, about OJ vvt.% to about 15 wt.% film-forming mixture is used, wherein the wt.% is relative to the tota! weight of the aqueous microcapsule composition. More typically, about 0.5 wt.% to about 10 wt.% is used. Most typically, about 1 wt.% to about 5 wt.% is used.

The aqueous microcapsule compositions of die instant disclosure also comprise an aqueous solvent The aqueous solvents of the instant disclosure include water-based solvents. Most typically, the aqueous solvent. is water.

The aqueous microcapsule compositions of the instant disclosure may comprise additional ingredients such as thickeners, lubricants (e.g^ Simethicone), conditioners, emulsifiers,. anti-perspirant active ingredients, oils, silicones, or waxes to create an emulsion,, preservatives (e.g.,, iodopropybyl h tyicarbamate), and other absorbent materials (e.g. , .perlite). If the compositions of the 'instant disclosure comprise a thickener, the thickener is typically either a hydrophi!ic thickener such as those described in U.S. 20.1 1 /0150805 (incorporated herein by reference) or a non-ionic thickenin polymer such as those polymers mentioned in U.S.

2010/0297051 {incorporated herein by reference).

The aqueous microcapsule, compositions of the instant disclosure are free of

formaldehyde. Thus, the aqueous microcapsule compositions' ate particularly suitable for use in aqueous-based personal care products.

Accordingly, another aspect of the disclosure relates to an aqueous-based, personal care product comprising the aqueous microcapsule composition of the instant disclosure. The aqueous-based personal care products of the instant disclosure may he wash-off products, which are understood to be those products that are applied for a given period of time and then are removed. These products include, but are not limited to, shampoos, conditioners, hair rinses, body washes, soaps, hand sanitizcrs, anti-perspirants, deodorants, perfumes., and cosmetics. The aqueous microcapsule composition according to the disclosure can be provided in all the formulation forms conventionally used for topical application and in particular in the form of aqueous gels or of aqueous, or aqueous/alcoholic solutions. They can also, by addition of a fatty or oily piiase, be provided in the form of dispersions of the lotion type, of emulsions with a liquid or semifiqoid consistency of the milk type, obtained by dispersion of a fatty phase in an aqueous phase (O/W) or vise versa (W/O), or of suspensions or emulsions with a soft, semisolid or solid consistency of the cream or gel type, or also of multiple (W/O/W or 0 W/O) emulsions, of microemulsio s, dfvesicular dispersions of ionic and/or nofiionic type, or of wax/aqueous phase dispersions. These aqueous microcapsule compositions are prepared according to the normal methods.

The aqueous-based personal care products of the instant disclosure include products used for the care or treatment of the skin, including the scalp, and lips., comprising an odorous substance. The aqueous microcapsule composition according to the. disclosure, can thus constitute a composition for scenting, caring for or treating keratinous substances arid can in particular be provided in die form of eau fraiche, eau de toilette, eau de parfuni, aftershave lotion, care water, silicon or aque us silkone care oil or anhydrous cream, it can. also be provided in the form of a scented two-phase lotion (eau de toilette phase/hydrocarbon oil and/or .silicon oil phase).

The disclosure also relates to aqueous microcapsule compositions packaged in a device equipped with an openwork wall, in particular a grating, packaged in a device equipped with a ball applicator (roil-on) or packaged in the form of a stick (e.g., an emulsion-based

antiperspirant/deodorant stick). In this respect, die aqueous microcapsule compositions comprise the Ingredients generally used In products of this type which are well known to a person skilled in the art

Another aspect of the disclosure relates to an anti-perspkant or a deodorant comprising an aqueoas microcapsule composition described herein. In a particular aspect of the present disclosure, the aqueous microcapsule compositions are incorporated into an snti-persplrant and or deodorant roll-on aqueous-based personal care product. The antl-perspirant and or deodorant aqueous-based personal, care product contains an effective amount of the aqueous microcapsule composition of the present disclosure, in addition to comprising aqueous, microcapsule compositions according to the instant disclosure* the anti-perspirant and/or deodorant aspect of the disclosure may comprise at least, one deodorant active principle and/pr at least one snti-perspiram salt or complex.

'Within the meaning, of the instant disclosure, "deodorant active principle" is understood to mean any substance capable of masking, absorbing, improving or .reducing the unpleasant odour resulting from the decomposition of human sweat by bacteria. Examples of such deodorant active principles that may be used in conjunction with the instantly disclosed compositions can be found in US. Patent Publications .20100196484, 20050031565,

20050238598 and 201102121.44, the entire disclosures of which are incorporated herein by reference.

More specifically, the deodorant active principles can be bacteriostatic agents or bactericidal, agents, such as 2,4I4,-irichioro-2,-hydroxydiphenyl ether (.RTM-Triclosan), 2,4- dichioro-2'-hydroxydiphenyl ether, S'^'J'-trichlorosalicylanilide, H3 4'-dieMoro-piieny -3~(4'~ chlorophenyl)urea f . T , Triclocarban) or 3,7,1 1 -trimethyidodeca-2,5, 10~trieno!

(.RTM.Famesol); quaternary ammonium salts, such as cetyltrimethyl-ammonium salts or cetylpyridinium salts, DPTA (i.3-diaminopropaneietraaceiic acid) or 1 ,2-decanedioi (Simc!ario! from Synirise).

Mention may also be made, amon the deodorant active principles in accordance with the disclosure, of zinc salts, such as zinc salicylate, zinc gluconate,, zinc pido!ate, zinc sulphate, zinc chloride, zinc lactate or zinc phenois iphonafe; cfalorhextdme and its salts; sodium bicarbonate; salicylic acid and its derivatives, such as 5-(n-octanoyl)salkylk acid; glycerol derivatives, such as, for example, caprylic/caprk giyeerides (Capmul MCM from. Abitec), glycerol capryiate or caprate (Der osoft GMC Y arid DermosoftGMC respectively from Straetmans) or polyglyceryl- 2 caprate (Dermosoft DG.MC from Siraeimans); bigua ide derivatives, such as

polyhexameihyie'ne >Iguanids salts; silver, zeolites or silver-free zeolites.

in the event of incompatibility or in order to .stabilize them, some of the active principles mentioned above can be incorporated in spherules., in particular vesicles, which may be ionic or nonsonic. and/or nanopa ticles (uanocap.su le and/or nanospheres).

The deodorant active principles are usually present In the aqueous microcapsule compositions according to the disclosure in concentrations ranging from 0,01 to 5% by weight, relativ to the total weight of the composition.

In order to improve the anliperspirant effectiveness of the composition, use may additionally be made of one or more water-soluble anionic polymers comprising a Bronsied add, in particular those deriving from malek acid and/or nraleic anhydride which are described in Patent Application WO 0:2/49590.

Furthermore, "anti-perspirant salt or complex," as used in the instant disclosure refers to any salt or complex which, by itself alone, has the effect of reducing or 'limiting the flow of sweat and/or absorbing human sweat. Examples of such anti-perspirant sail or complexes can be found in the OTC final monograph on Antiperspirant Actives and OS. Patent Publications

20100196484, 2OO5O031565, 20050238598, and 20110212144, the entire disclosures of which are incorporated herein by reference.

The antiperspirant salts or complexes in accordance with the disclosure are generally chosen from aluminium, and/or zirconium salts or complexes. They are typically chosen from aluminium hydroh slides; aluminium zirconium hydrohaiides, or complexes of zirconium hydrochloride, and of aluminium hydroxychlorj.de. with or without an amino acid, such as those described in U.S. Pat. No. 3,792,068.

Mention may in particular be made, among the aluminium salts, -of aluminium, c-h!orohydrate in the activated or nonaciivated form, aluminium chlorchydrex, the aluminium ch iorohy drex- .polyeth lene glycol complex, the aluminium ehlorohydrex propylene glycol complex, aluminium dichlorohydrate, the aluminium diciiiorohydrex polyethylene glycol complex, the aluminium dich.iorohydrex propylene glycol complex, aluminium

ses uichlorohydrate, the aluminium sesquichlorohydrex polyethylene glycol complex, the aluminium sesquichlorohydrex propylene glycol complex or aluminium sulphate buffered with sodium alumin um lactate.

Mention may in particular be made, among aluminium zirconium, salts, of aluminium zirconium ociachloro-hydmte, aluminium zirconium pentachlorohydrate, aluminium zirconium tefrachiorohydrate or aluminium zirconium trichlorohydrate.

The complexes of zirconium hydroxychloride. and of aluminium h droxy chloride with an amino acid are generally known under the name ZAG (when the amino acid is glycine). Mention may be made, among these products, of the aluminium zirconium octachiorohydrex glycine. aluminium zirconium pentaohiorohydrex glycine, aluminium zirconium tetrathiorohydrex glycine and aluminium zirconium trichlorohydrex glycine complexes.

Use will more particularly be made of aluminium chlorohydrate in the activated or nonactiva ed form.

The antiperspirant salts or complexes can be present in the aqueous microcapsule composition according to the disclosure in concentration of approximately 0.5 to 25% by weight, relative to the total weight of the aqueous microcapsule composition.

Another aspect of the disclosure relates to a method of depositing the plurality of microcapsule particles of the aqueous microcapsule composition described herein on a substrate. The term '"substrate," as used herein, includes, but is not limited to, human feeratinous substances, fabric or textile materials (e.g., garments, clothes, towels, sheets, accessories, hats, gloves, outerwear, curtains, rugs, or stuffed animals);, or hard surfaces (e.g., wood, tile, linoleum, countertops, or dishes]. The. microcapsule particles are deposited by applying the aqueous microcapsule composi tion of the. instant disclosure to the desired substrate. A partic ular aspect of the. present disclosure invol es .applying the aqueous microcapsule composition described herein on a substrate during washing and/or rinsing processes (e.g., during a washing or rinsing cycle for a clothes, or dishwasher).

Once deposited, the microcapsules release the volatile oil-soluble active ingredient contained therein through small cracks or imperfections in the .microcapsule wall caused by drying, physical or mechanical means, or by large-scale rupture of the microcapsule wall. In each of these cases, the volatility of the encapsulated volatile oil-soluble active ingredient is critical to both the speed and duration of release, which in turn control consumer perception. Thus, volatile oil-soluble active ingredients which have higher volatility as evidenced by normal boiling points of less than 250° Celsius, and more typically less than about -225° Celsius are used in cases where quick release and impact of the volatile oil-soluble active ingredient is desired, in contrast, volatile oil-soluble active, ingredients that have lower volatility (e.g. , having boiling points greater than 225° Celsius) are used when a longer duration of the volatile oil-soluble active ingredient is desired. Volatile oil-soluble active ingredients of the instant disclosure may be combined in any proportion to achie ve the desired speed and d uration of perception.

A particular aspect of the present disclosure relates to a method of scenting or fragrancmg a substrate comprising applying an aqueous microcapsule composition described herein to- he substrate. In order to provide the highest fragrance impact from the microcapsule particles deposited on the various substrates' referenced above, materials with a high odor-activity are typically used as the volatile oil-soluble active ingredient. Materials with high odor-activity can be detected by sensory receptors at low concentrations In air, thus providing high fragrance perception from low levels of deposited capsules.. This properly must be balanced with the volatility as described above. Some of the principles mentioned above are disclosed in U.S. Pat, No. 5,1 12,688. Examples of fragrance ingredients that may be used as volatile oil-soluble active ingredients in the microcapsule particles of the instant ' disclosure include, but are not limited to, the fragrance' ingredients listed in Table 1 of U.S. 2010/0143422 which is incorporated 'herein by reference.

Usually, higher ClogP materials are used, meaning that those materials with a ClogP value of 4.5 are employed more typically than those fragrance materials with a ClogP of 4. and those materials are used more typically than fragrance, materials with a ClogP of 3.3.

When used to scent or fragrance a substrate, the volatile oil-soluble active ingredient of the aqueous microcapsule compositions described herein should comprise at least about 40 weight percent of materials with C gP greater than 3.3, more typically greater than about 80 weight percent of materials and most typically greater than about 90 weight percent of materials with C!ogP greater than 4 wherein the weight percent, in each ease, is based on the total dry weight of the microcapsule particle. In an additional embodiment, the aqueous microcapsule composition may contain a volatile oil-soluble active ingredient comprising fragrance materials with a CiogP greater than abou 1.5.

Those with skill in Che art appreciate that fragrance formulations are frequently complex mixtures of .many fragrance ingredients. A perfumer commonly has several thousand fragrance chemicals to work from. Those with skill in the art appreciate thai the aqueous microcapsule compositions of the instant disclosure may contain a single ingredient, but it is much more likely that the compositions described herein will comprise at least eight or more fragrance chemicals, more likely to contai twelve or more and often twenty or more fragrance chemicals. The present disclosure also contemplates the -use of complex fragrance: formulations containing fifty or more fragrance chemicals, seventy five or more or even a hundred Or more fragrance chemicals in a fragrance formulation.

Usually, fragrance materials used as the volatile oil-soluble active ingredient will have both high CiogP and high vapor pressure. Among those having these properties are: Para cymene, Caphene, andarinal Firm, Vivaldie, Terp nene, Verdox, Fenchyl acetate, Cyeiohexyl isovalerate, Mar&anate, Myrcene, Herbavert, Isoburyi isobutyrate, Teirahydrocitral, Ocimene and CaryophyHeise.

Yet another aspect of the disclosure relates to a method of treating {e.g., a method of inhibiting, preventing, or reducing) human body odours comprising applying an effective amount of an aqueous microcapsule composition described herein to a surface of human skin. The human skin may be, for example, armpit skin or foot skin. When used to treat human body odours, the volatile oil-soluble active ingredient comprises at least one deodorant active principle and/or at least one anti-perspirant salt or complex.

The following examples are provided as specific aspects of the present disclosure. These and additional modifications and improvement of the present disclosure may also be apparent to those with ordinary skill in the art. The particular combinations of elements described and 'illustrated, herein are intended only to represent. certain aspects of the present disclosure and are not intended to serve as limitations of 'alternative articles within the. spirit, and scope of the disclosure.

EXAMPLE 1

Antiperspirant Deodorafit Aqueous Microcapsule Composition for Roll-On An antiperspirant/deodorant aqueous microcapsule composition to be incorporated in a

'ball-top dispenser of the roil-on type was prepared by adding by small portions a mixture comprising:

274.13 grains of Water

5.00 grams Steareih-ί QO/PEG-i 36 HDI Copolymer

150.00 grams Aluminum Chlorohydrate

35.00 grams Dimethicons

15.00 grams CI -22 Alcohols and CI 2-20 Alky! Glycoside

0.38 grams lodopropynyi Buty {carbamate

5.00 grams Peril te

7.50 grams Fragrance

8.00 grams Encapsulated Fragrance

The mixture was formed, from two phases as described below.

PHASE A: Steareth- 100/PEG- 136/HDi copolymer was sprinkled on hot water (ie., water having a temperature of approximately 80° Celsius) contained in a vessel for 30 minutes under homogenizing agitation. Aluminum chiorohydrate solution was then added to the vessel containing the steareUv- 100 PEG- i 36/HDI copolyrner/water mixture. The vessel was heated, using a hot water bath, to approximately 80° Celsius, and the mixture was stirred until, uniform.

PHASE B: Oimethicone and the C 14-22 Alcohols and CI 2-20 Alky] Glycoside mixture were mixed in a vessel, and the vessel was heated, using a hot water bath, to approximately -80°

Celsius.

The contents of the vessel, used in PHASE B were then introduced to the vessel containing the PHASE A contents with U!traTurrax stirring. The- contents of the PHASE B vessel were mixed wit the contents of the PHASE A vessel for approximately .20 minutes. After.20 minutes elapsed, the vessel containing the PHASE A and PHASE B contents was removed from the hoi water bath and die contents of the vessel were mixed using- sweep, blade mixing. Onc the vessel reached approximately 55 0 Celsius, iodopropynyl batylcarbamaie and perlite were added. The contents of the vessel were then mixed until uniform. The vessel was then cooled to a temperature of approximately 25-° Celsius, and free fragrance and encapsaJated fragrance were added-. The contents of the vessel were then raked until a uniform mixture was formed.

All publications cited, hi the specification, both patent publications and non-patent publications are indicative of the level of skill -of those skilled in the art to which this disclosure pertains. Any publication not already Incorporated by reference herein, is herein incorporated by reference to the same extent as if each individual publication were specifically and individually indicated as being incorporated by reference.

Still other objects and advantages of the present disclosure will become readily apparent by those skilled in the art from the preceding detailed description, wherein it is shown and described preferred embodiments, simply by way of illustration of the best mode contemplated. As will be realized the disclosure is capable of other and different embodiments, and its several details are capable of modifications in various obvious respects, without departing from the disclosure. Accordingly, the description is to be regarded as. illustrative in nature and not as restrictive.